Evidence map›Paper›PMID 29578208›Full record

ReviewNature reviews. Nephrology2018

Angiotensin-converting enzyme in innate and adaptive immunity.

Kenneth E Bernstein, Zakir Khan, Jorge F Giani, Duo-Yao Cao, Ellen A Bernstein, Xiao Z Shen

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06539234 (Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II in Relation to Hemodynamic Response to Treatment With Angiotensin II.), which is not on this map. Cited by 138 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 2 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06539234 recruitingnot on this mapstarted 2024, after this paper: background citation

Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II in Relation to Hemodynamic Response to Treatment With Angiotensin II.

TypeobservationalSponsorUniversity Medical Centre MariborRan2024 to 2026Enrolled80ConditionsShock, Vasoplegic Syndrome
3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 2 syntheses or guidelines pooled it, 252 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kenneth E BernsteinDepartment of Biomedical Sciences, Cedars-Sinai Medical Center.
Zakir KhanDepartment of Biomedical Sciences, Cedars-Sinai Medical Center.
Jorge F GianiDepartment of Biomedical Sciences, Cedars-Sinai Medical Center.
Duo-Yao CaoDepartment of Biomedical Sciences, Cedars-Sinai Medical Center.
Ellen A BernsteinDepartment of Biomedical Sciences, Cedars-Sinai Medical Center.
Xiao Z ShenDepartment of Physiology, Zhejiang University School of Medicine, Hangzhou, China.
Cedars-Sinai Medical Center · USZhejiang University · CN

Funding

The Role of Inflammation in Cardiovascular DiseaseP01HL129941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRISON, DAVID G · 2016 to 2020
$12.4M
Renal ACE, salt sensitivity and blood pressure controlR03DK101592 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI GONZALEZ-VILLALOBOS, ROMER ANDRES · 2014 to 2016
$638k
Carboxypeptidase ACE and MHC Class I PresentationR21AI114965 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2015 to 2016
$481k
NHLBI NIH HHS P01 HL129941NIAID NIH HHS R21 AI114965NIDDK NIH HHS R03 DK101592
6 · The paper itself

Abstract

Angiotensin-converting enzyme (ACE) - a zinc-dependent dicarboxypeptidase with two catalytic domains - plays a major part in blood pressure regulation by converting angiotensin I to angiotensin II. However, ACE cleaves many peptides besides angiotensin I and thereby affects diverse physiological functions, including renal development and male reproduction. In addition, ACE has a role in both innate and adaptive responses by modulating macrophage and neutrophil function - effects that are magnified when these cells overexpress ACE. Macrophages that overexpress ACE are more effective against tumours and infections. Neutrophils that overexpress ACE have an increased production of superoxide, which increases their ability to kill bacteria. These effects are due to increased ACE activity but are independent of angiotensin II. ACE also affects the display of major histocompatibility complex (MHC) class I and MHC class II peptides, potentially by enzymatically trimming these peptides. Understanding how ACE expression and activity affect myeloid cells may hold great promise for therapeutic manipulation, including the treatment of both infection and malignancy.

Indexed as

Adaptive ImmunityImmunity, InnateAnimalsHumansPeptidyl-Dipeptidase APeptidyl-Dipeptidase A

Identifiers

PMID29578208
PMCPMC6192041
OpenAlexW2792274845

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.